Evidence map›Paper›PMID 12915584›Full record

ArticleJournal of virology2003

High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease.

Peter K C Goon, Tadahiko Igakura, Emmanuel Hanon, Angelina J Mosley, Becca Asquith, Keith G Gould, Graham P Taylor, Jonathan N Weber, Charles R M Bangham

Abstract read
In one paragraph

Article in Journal of virology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Trial
  2. Complete Rescue of HTLV-1Pathogens (Basel, Switzerland) · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. The Predominant CD4Clinical and vaccine immunology : CVI · 2017
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Helminthic infection and the risk of neurologic disease progression in HTLV-1.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2012
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Peter K C GoonDepartment of Immunology, Imperial College London, London W2 1PG, United Kingdom.
Tadahiko Igakura
Emmanuel Hanon
Angelina J Mosley
Becca Asquith
Keith G Gould
Graham P Taylor
Jonathan N Weber
Charles R M Bangham

Funding

Wellcome Trust
6 · The paper itself

Abstract

Significantly higher frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4(+) T cells were present in the peripheral blood mononuclear cells of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients than in those of asymptomatic carriers with similar provirus loads. The data suggest that HTLV-1-specific CD4(+) T cells play a role in the pathogenesis of HAM/TSP.

Indexed as

Carrier StateCD4 Lymphocyte CountCD4-Positive T-LymphocytesEnterotoxinsHumansHuman T-lymphotropic virus 1Interferon-gammaInterleukin-2In Vitro TechniquesLymphotoxin-alphaParaparesis, Tropical SpasticProvirusesTetradecanoylphorbol AcetateTumor Necrosis Factor-alphaenterotoxin B, staphylococcalEnterotoxinsInterferon-gammaInterleukin-2Lymphotoxin-alphaTetradecanoylphorbol AcetateTumor Necrosis Factor-alpha

Identifiers

PMID12915584
PMCPMC187419

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.